Redesigned proficiency testing materials improve for prostate-specific antigen: A College of American Pathologists ligand assay survey study

Archives of Pathology and Laboratory Medicine

Volumn 124, Issue 11, 2000, Pages 1608-1613

  Sokoll, L J ^a   Witte, D L ^a   Klee, G G ^a   Chan, D W ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; PROSTATE SPECIFIC ANTIGEN;

ANTIGEN DETECTION; ARTICLE; CONCENTRATION RESPONSE; FOOD AND DRUG ADMINISTRATION; HUMAN; IMMUNOASSAY; MATERIALS TESTING; SPERM;

HUMANS; IMMUNOASSAY; LIGANDS; MALE; PROSTATE-SPECIFIC ANTIGEN; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS;

EID: 0033730794     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Production, analysis, and characterization of reference materials for prostate specific antigen
2. Standardization of immunoassays for prostate-specific antigen
3. Variation in the quantitation of prostate-specific antigen in reference material: Differences in commercial immunoassays
4. Effect of the ratio of free to total prostate-specific antigen on interassay variability in proficiency test samples
5. Assay for prostate specific antigen (PSA): Problems and possible solutions
6. Issues in the assessment of PSA immunoassays
7. Discordance of assay methods creates pitfalls for the interpretation of prostate-specific antigen values
8. Current status and future direction in standardization of prostate-specific antigen immunoassay
9. A complex between prostate-specific antigen and alpha-1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostate cancer: Assay of the complex improves clinical sensitivity for cancer
10. 1-antichymotrypsin as an indicator of prostate cancer
11. Prostate-specific antigen as a marker for prostatic cancer: A monoclonal and a polyclonal immunoassay compared
12. Comparison of a polyclonal and monoclonal immunoassay for PSA: Need for an international antigen standard
13. Molecular forms of prostate-specific antigen and the human kallikrein gene family: A new era
14. Total, free, and complexed PSA: Analysis and clinical utility
15. Human kallikrein 2 (hk2) and prostate-specific antigen (PSA): Two closely related, but distinct, kallikreins in the prostate
16. Multiple forms of prostate-specific antigen in serum: Differences in immunorecognition by monoclonal and polyclonal assays
17. Comparison between equimolar- and skewed-response assays of prostate-specific antigen: Is there an influence on the clinical significance when measuring total serum prostate-specific antigen?
18. Role of free PSA in discordance across commercial PSA assays
19. Five PSA methods compared by assaying samples with defined PSA ratios
20. Technicon immuno 1 PSA assay measures both free and alpha-1-antichymotrypsin-complexed prostate-specific antigen on an equimolar basis
21. Epitope analysis of prostate-specific antigen (PSA) C-terminal-specific monoclonal antibody and new aspects for the discrepancy between equimolar and skewed PSA assays
22. Different molecular forms of uncomplexed prostate specific antigen (PSA) show similar immunoreactivities
23. Reactivity of free and complexed forms of PSA: Examination of CAP survey discrepancies
24. Second Stanford conference on international standardization of prostate-specific antigen immunoassays: September 1 and 2, 1994
25. Analytical performance of free PSA immunoassays: Results from an interlaboratory survey
26. Clinical evaluation of three free prostate specific antigen (PSA) assays in combination with different total PSA assays
27. Interpretation of free prostate specific antigen clinical research studies for the detection of prostate cancer
28. Comparison of prostate-specific antigen (PSA) measured by four combinations of free PSA and total PSA
29. Comparison of 3 investigational assays for the free form of prostate specific antigen